m+Medelevator.RU
← Поиск публикаций
Exploration (Beijing, China) · 2026

Cuproptosis-Related Genes in Immune Infiltration and Diagnosis in Hepatitis B Virus-Related Acute Liver Failure.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Deng Jingwen, Zhu Tao, Wang Yueyang, Zhang Sitong, Deng Hong, Quan Guilan, Peng Tingting, Wu Chuanbin, Cai Huiqiang, Lu Chao, Cai Xiaopeng

Аннотация

Hepatitis B virus (HBV) infection poses a significant challenge to global health, particularly in developing countries such as China, where HBV-related acute liver failure (HBV-ALF) is a prominent cause of acute liver failure. This study investigated the effect of cuproptosis, a recently identified form of cell death, on immune infiltration in HBV-ALF. We mined the gene expression data of HBV-ALF from the Gene Expression Omnibus database. Through enrichment analysis of differentially expressed genes (DEGs), pathways related to the response to metal/copper ions and the acute inflammatory response were found to be enriched. We subsequently found that HBV-ALF tissues contained more copper ions and conducted an intersection analysis of DEGs and cuproptosis-related genes (CRGs), which resulted in the identification of 7 core cuproptosis-related DEGs (CR-DEGs) for further investigation with a diagnostic model. Immune infiltration analysis and unsupervised clustering analysis revealed distinct patterns in HBV-ALF and the possibility of crosstalk between ferroptosis and cuproptosis. Furthermore, we identified 17 transcription factors, 90 miRNAs, and 15 drugs that might interact with the 7 CR-DEGs. To validate our findings and their clinical significance, we verified the diagnostic value and immune infiltration patterns of the 7 CR-DEGs in both the testing dataset, cell line, and clinical samples. In conclusion, our findings indicated that these 7 CR-DEGs demonstrate promising diagnostic value and may represent viable therapeutic targets for individuals with HBV-ALF.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты